Literature DB >> 11021825

Fibronectin-mononuclear cell interactions regulate type 1 helper T cell cytokine network in tolerant transplant recipients.

A J Coito1, K Onodera, H Kato, R W Busuttil, J W Kupiec-Weglinski.   

Abstract

Fibronectin (FN), expressed primarily by macrophages, endothelial cells, and smooth muscle cells, represents an integral feature of the rejection response in transplant recipients. Here we demonstrate a unique pattern of cellular FN expression in rat recipients of cardiac allografts rendered tolerant in an infectious manner with either nondepleting CD4 mAb or regulatory spleen cells. Unlike in rejecting controls, cellular FN in tolerant hosts was restricted to the graft vessels and no vascular cell adhesion molecule-1 or intercellular adhesion molecule-1 expression could be found, supporting the role of FN in leukocyte sequestration at the graft site. The lack of myocardial FN in tolerant rats, despite dense macrophage infiltration, correlated with profound depression of Th1 (interleukin-2 and interferon-gamma) cytokines. Treatment with CD4-depleting mAb prevented tolerance induction and restored myocardial expression of FN in parallel with marked increase in the expression of interleukin-2 and interferon-gamma mRNA/protein. Furthermore, connective segment-1 peptide-facilitated adjunctive blockade of FN-alpha4beta1 interactions in recipients conditioned with CD4 depleting mAb, significantly depressed intragraft expression of interleukin-2 and interferon-gamma mRNA/protein. Hence, the lack of FN associated with infiltrating leukocytes plays an important role in the maintenance of tolerance in transplant recipients by depressing local expression of Th1 cytokines that otherwise facilitate acute graft rejection.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11021825      PMCID: PMC1850166          DOI: 10.1016/S0002-9440(10)64636-6

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  78 in total

1.  Augmentation of mature CD4+ T cell responses to isolated antigenic class II proteins by fibronectin and intercellular adhesion molecule-1.

Authors:  A Brunmark; A M O'Rourke
Journal:  J Immunol       Date:  1997-08-15       Impact factor: 5.422

2.  Fibronectin receptor functions in embryonic cells deficient in alpha 5 beta 1 integrin can be replaced by alpha V integrins.

Authors:  J T Yang; R O Hynes
Journal:  Mol Biol Cell       Date:  1996-11       Impact factor: 4.138

3.  Fibronectin type III5 repeat contains a novel cell adhesion sequence, KLDAPT, which binds activated alpha4beta1 and alpha4beta7 integrins.

Authors:  J V Moyano; B Carnemolla; C Domínguez-Jiménez; M García-Gila; J P Albar; P Sánchez-Aparicio; A Leprini; G Querzé; L Zardi; A Garcia-Pardo
Journal:  J Biol Chem       Date:  1997-10-03       Impact factor: 5.157

4.  Mesodermal development in mouse embryos mutant for fibronectin.

Authors:  E N Georges-Labouesse; E L George; H Rayburn; R O Hynes
Journal:  Dev Dyn       Date:  1996-10       Impact factor: 3.780

5.  Human monocyte binding to fibronectin enhances IFN-gamma-induced early signaling events.

Authors:  J B McCarthy; B V Vachhani; S M Wahl; D S Finbloom; G M Feldman
Journal:  J Immunol       Date:  1997-09-01       Impact factor: 5.422

6.  Expression of fibronectin splicing variants in organ transplantation: a differential pattern between rat cardiac allografts and isografts.

Authors:  A J Coito; L F Brown; J H Peters; J W Kupiec-Weglinski; L van de Water
Journal:  Am J Pathol       Date:  1997-05       Impact factor: 4.307

7.  CD7-mediated regulation of integrin adhesiveness on human T cells involves tyrosine phosphorylation-dependent activation of phosphatidylinositol 3-kinase.

Authors:  A S Chan; J L Mobley; G B Fields; Y Shimizu
Journal:  J Immunol       Date:  1997-07-15       Impact factor: 5.422

8.  Type 2 helper T cell-type cytokines and the development of "infectious" tolerance in rat cardiac allograft recipients.

Authors:  K Onodera; W W Hancock; E Graser; M Lehmann; M H Sayegh; T B Strom; H D Volk; J W Kupiec-Weglinski
Journal:  J Immunol       Date:  1997-02-15       Impact factor: 5.422

9.  Blockade of very late antigen-4 integrin binding to fibronectin in allograft recipients: I. Treatment with connecting segment-1 peptides prevents acute rejection by suppressing intragraft mononuclear cell accumulation, endothelial activation, and cytokine expression.

Authors:  A J Coito; S Korom; E Graser; H D Volk; L Van De Water; J W Kupiec-Weglinski
Journal:  Transplantation       Date:  1998-03-15       Impact factor: 4.939

10.  Alpha 4 beta 1 integrin-mediated tyrosine phosphorylation in human T cells: characterization of Crk- and Fyn-associated substrates (pp105, pp115, and human enhancer of filamentation-1) and integrin-dependent activation of p59fyn1.

Authors:  A J Hunter; Y Shimizu
Journal:  J Immunol       Date:  1997-11-15       Impact factor: 5.422

View more
  8 in total

1.  VLA-4 integrin concentrates at the peripheral supramolecular activation complex of the immune synapse and drives T helper 1 responses.

Authors:  María Mittelbrunn; Ana Molina; María M Escribese; María Yáñez-Mó; Ester Escudero; Angeles Ursa; Reyes Tejedor; Francisco Mampaso; Francisco Sánchez-Madrid
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-19       Impact factor: 11.205

2.  Fibronectin-alpha4beta1 integrin interactions regulate metalloproteinase-9 expression in steatotic liver ischemia and reperfusion injury.

Authors:  Carolina Moore; Xiu-Da Shen; Feng Gao; Ronald W Busuttil; Ana J Coito
Journal:  Am J Pathol       Date:  2007-02       Impact factor: 4.307

3.  Recipient-derived EDA fibronectin promotes cardiac allograft fibrosis.

Authors:  Adam J Booth; Sherri C Wood; Ashley M Cornett; Alyssa A Dreffs; Guanyi Lu; Andrés F Muro; Eric S White; D Keith Bishop
Journal:  J Pathol       Date:  2012-01-04       Impact factor: 7.996

4.  Mucosal tolerance to E-selectin and response to systemic inflammation.

Authors:  Kachi Illoh; Catherine Campbell; Orieji Illoh; John Diehl; James Cherry; Abdel Elkhaloun; Yong Chen; John Hallenbeck
Journal:  J Cereb Blood Flow Metab       Date:  2006-04-05       Impact factor: 6.200

Review 5.  Therapeutic anti-integrin (alpha4 and alphaL) monoclonal antibodies: two-edged swords?

Authors:  Roberto González-Amaro; María Mittelbrunn; Francisco Sánchez-Madrid
Journal:  Immunology       Date:  2005-11       Impact factor: 7.397

6.  Cell adhesion protein fibulin-7 and its C-terminal fragment negatively regulate monocyte and macrophage migration and functions in vitro and in vivo.

Authors:  Pranita P Sarangi; Papiya Chakraborty; Shiba Prasad Dash; Tomoko Ikeuchi; Susana de Vega; Kiran Ambatipudi; Larry Wahl; Yoshihiko Yamada
Journal:  FASEB J       Date:  2018-04-10       Impact factor: 5.191

7.  Fibronectin-alpha 4 beta 1 integrin-mediated blockade protects genetically fat Zucker rat livers from ischemia/reperfusion injury.

Authors:  Farin Amersi; Xiu-Da Shen; Carolina Moore; Judy Melinek; Ronald W Busuttil; Jerzy W Kupiec-Weglinski; Ana J Coito
Journal:  Am J Pathol       Date:  2003-04       Impact factor: 4.307

8.  Direct evidence for activated CD8+ T cell transmigration across portal vein endothelial cells in liver graft rejection.

Authors:  Taro Kariya; Hisashi Ueta; Xue-Dong Xu; Daisuke Koga; Taichi Ezaki; Enqiao Yu; Satoshi Kusumi; Yusuke Kitazawa; Yasushi Sawanobori; Tatsuo Ushiki; Thomas Issekutz; Kenjiro Matsuno
Journal:  J Gastroenterol       Date:  2016-02-18       Impact factor: 7.527

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.